Skip to content

Comparison of clinical outcome and radiographic between BMP-2 and beta-Tricalcium phosphate plus iliac bone graft in XLIF surgery

Comparison of clinical outcome and radiographic between bone morphogenetic protein-2 and beta-Tricalcium phosphate plus iliac bone graft in extreme lateral interbody fusion surgery : Ambidirectional cohort study

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20240618007
Enrollment
48
Registered
2024-06-18
Start date
2015-01-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fusion rate in patient who has spondylosis or spondylolithesis, and surgery lumbar spine by XLIF surgery (Extreme lateral interbody fusion) comparing between use BMP-2 and beta-tricalcium phosphate spondylosis, lumbarsacral , BMP-2, beta tricalcium phosphate

Interventions

Patients who have undergo XLIF (Lumbar fusion) surgery and used BMP-2 protein for fusion at interbody,Patients who have undergo XLIF (Lumbar fusion) surgery and used Beta-tricalcium phosphate with ili
Treatment,Treatment
Use BMP2,Use tricalcium phosphate

Sponsors

Department of orthopedics surgery and physical therapy, Faculty of medicine Siriraj hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patient who was diagnosed : Lumbar spondylosis, 2. Patient who was diagnosed : Lumbar spondylolithesis, 3. All patients who have undergone surgery XLIF

Exclusion criteria

Exclusion criteria: 1. Patient who has severe complication in post-op surgery such as : Sepsis, Hemodynamic unstable, Stroke 2. Complication at post-operative follow up such as : Surgical site infection, Implant failure, Malignant at spine

Design outcomes

Primary

MeasureTime frame
Fusion rate 6 months, 12 months and 24 months after surgery Bridwell interbody fusion grading system,Fusion rate 6 months, 12 months and 24 months after surgery Film LS spine flexion and extension ( parameter such as lumbar lordosis, interforaminal distance)

Secondary

MeasureTime frame
Clinical outcome 6 months, 12 months and 24 months after surgery ODI (Oswestry Disability Index) scoring,Clinical outcome 6 months, 12 months and 24 months after surgery EQ-5D-5L (Health-related quality of life measure),Pain score 6 months, 12 months and 24 months after surgery Pain NRS (Numeric rating scale)

Countries

Thailand

Contacts

Public ContactApicha Leardthanadee

Siriraj hospital

siiro@mahidol.ac.th024197968

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026